483
Olga M. Lapeyra, M.D.FDA 483 - Olga M. Lapeyra, M.D. - October 25, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Olga M. Lapeyra, M.D., Clinical Investigator, revealed significant deficiencies in the conduct of a clinical study. The firm failed to maintain adequate case histories, specifically regarding investigational product dosage documentation for multiple subjects. Additionally, the investigation was not conducted according to the protocol, as the firm did not properly monitor and report temperature excursions for the investigational product.
Open in Dashboard
ID · cc20d587-7c8e-4143-9868-c70123b84fa8